Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Alirocumab Plus Cemiplimab in Immunorefractory NSCLC: A Single Arm Phase 2 Study.
Journal: Research square
Published: July 03, 2026
Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study.
Journal: Future oncology (London, England)
Published: April 06, 2026
Machine Learning Assessment of Pathologic Response in Lung Cancer Resections After Neoadjuvant Therapy-IASLC MPR Project.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 25, 2025
Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy - IASLC MPR Project.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 25, 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation.
Journal: Journal for immunotherapy of cancer
Published: October 07, 2025
Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies.
Journal: Cancer cell
Published: July 19, 2025
cytoGPNet: Enhancing Clinical Outcome Prediction Accuracy Using Longitudinal Cytometry Data in Small Cohort Studies.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Tumor-Associated Molecules Lead the Way to New Therapies for Small Cell Lung Cancer.
Journal: JCO oncology practice
Published: April 02, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2024
Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment.
Journal: Cancer reports (Hoboken, N.J.)
Published: September 16, 2024
Last Updated: 09/26/2026